Biomarin Pharmaceuticals (NQ: BMRN )

69.51 +1.35 (+1.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
January 09, 2017
Form 4
Source: SEC/Edgar
January 02, 2017
Form 4
Source: SEC/Edgar
November 28, 2016
Form 4
Source: SEC/Edgar
November 22, 2016
Form 4
Source: SEC/Edgar
November 21, 2016
Form 4
Source: SEC/Edgar
November 17, 2016
Form 4
Source: SEC/Edgar
November 13, 2016
Form 4
Source: SEC/Edgar
November 13, 2016
Form 4
Source: SEC/Edgar
November 08, 2016
Form 4
Source: SEC/Edgar
October 30, 2016
Form 4
Source: SEC/Edgar
October 18, 2016
Form 4
Source: SEC/Edgar
October 16, 2016
Form 4
Source: SEC/Edgar
October 03, 2016
Form 4
Source: SEC/Edgar
October 02, 2016
Form 4
Source: SEC/Edgar
September 28, 2016
Form 4
Source: SEC/Edgar
September 18, 2016
Form 4/A
Source: SEC/Edgar
August 31, 2016
Form 4/A
Source: SEC/Edgar
August 31, 2016
Form 4
Source: SEC/Edgar
August 29, 2016
Form 4
Source: SEC/Edgar
August 16, 2016
Form 4
Source: SEC/Edgar
August 02, 2016
Form 4
Source: SEC/Edgar
August 02, 2016
Form 4
Source: SEC/Edgar
August 02, 2016
Form 4
Source: SEC/Edgar
July 27, 2016
Form 4
Source: SEC/Edgar
July 25, 2016
Form 4
Source: SEC/Edgar
July 19, 2016
Form 3
Source: SEC/Edgar
July 18, 2016
Form 4
Source: SEC/Edgar
July 18, 2016
Form 3
Source: SEC/Edgar
July 18, 2016
Form 4
Source: SEC/Edgar
July 18, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.